Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Oxybutynin chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxybutynin chloride and what is the scope of oxybutynin chloride freedom to operate?

Oxybutynin chloride
is the generic ingredient in four branded drugs marketed by Mylan, Osmotica Pharm Us, Allergan Sales Llc, Amneal Pharms, Ortho Mcneil Janssen, Silarx, Unique Pharm Labs, Usl Pharma, Pharm Assoc, Accord Hlthcare, Mikart, Mylan Pharms Inc, Impax Pharms, Teva Pharms Usa, Wockhardt, Janssen Pharms, Vintage Pharms, Watson Labs, Quantum Pharmics, and Apotex Inc, and is included in twenty-three NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Oxybutynin chloride has seventy-four patent family members in twenty countries.

There are sixteen drug master file entries for oxybutynin chloride. Forty-nine suppliers are listed for this compound.

Summary for Generic Name: oxybutynin chloride

Drug Master File Entries: see list16
Suppliers / Packagers: see list49
Bulk Api Vendors: see list49
Clinical Trials: see list222
Patent Applications: see list2,039
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxybutynin chloride at DailyMed

Pharmacology for Ingredient: oxybutynin chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unique Pharm Labs
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL206121-002May 27, 2016ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL204010-001Nov 23, 2015ABRXNoNo► Subscribe► Subscribe
Osmotica Pharm Us
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL078503-002Feb 4, 2009ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076644-002May 10, 2007ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076644-001Nov 9, 2006ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus